|
Market Closed -
Warsaw S.E.
11:55:50 2026-09-02 am EDT
|
5-day change | 1st Jan Change | ||
| 130.00 PLN | -1.07% |
|
-7.28% | -4.55% |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| May. 15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
| Market Cap | 412M 110M 95.21M 89.68M 81.9M 153M 10.48B 154M 1.06B 5.34B 414M 405M 17.54B | P/E 2026 * |
-7.56x | P/E 2027 * | 1.03x |
|---|---|---|---|---|---|
| Enterprise Value | 315M 84.34M 72.76M 68.54M 62.59M 117M 8.01B 118M 811M 4.08B 317M 310M 13.41B | EV / Sales 2026 * |
126x | EV / Sales 2027 * | - |
| Free-Float |
77.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.07% | ||
| 1 week | -7.28% | ||
| Current month | -2.99% | ||
| 1 month | +4.33% | ||
| 3 months | +5.18% | ||
| 6 months | -12.40% | ||
| Current year | -4.55% |
| 1 week | 125.4 |  | 141 |
| 1 month | 125.2 | | 141 |
| Current year | 109 | | 159.2 |
| 1 year | 109 | | 182.2 |
| 3 years | 109 | | 239 |
| 5 years | 83 | | 348 |
| 10 years | 9.55 | | 348 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcin Izydorzak
PRN | Corporate Officer/Principal | 52 | - |
Piotr Garstecki
CEO | Chief Executive Officer | 50 | - |
Szymon Ruta
DFI | Director of Finance/CFO | 50 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 2017-03-06 | |
| Director/Board Member | 50 | 2017-03-06 | |
| Director/Board Member | 63 | 2017-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/15/26 | Others | Chairman | 140,000 | 4.4188% | ||
| 1/15/26 | Buy | Chairman | 36,000 | 1.1363% | ||
| 1/15/26 | Sell | Chairman | 36,000 | 1.1363% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.07% | -7.28% | -16.99% | -21.92% | 112M | |
| +1.31% | -6.06% | +87.10% | +262.11% | 3.88B | |
| +4.11% | +2.13% | +286.55% | +40.16% | 3.75B | |
| +3.34% | +1.91% | +47.92% | +68.09% | 3.49B | |
| +1.29% | -2.36% | +263.10% | +409.76% | 2.53B | |
| -2.35% | -7.08% | -29.90% | -29.70% | 2.21B | |
| +3.11% | +9.01% | +44.15% | - | 1.64B | |
| -2.73% | +2.07% | +25.64% | +45.25% | 1.1B | |
| +1.10% | -18.00% | +204.96% | -28.35% | 1.09B | |
| -3.61% | -9.62% | +20.37% | +62.07% | 642M | |
| Average | +0.07% | -4.92% | +93.29% | +89.72% | 2.04B | |
| Weighted average by Cap. | +0.82% | -3.91% | +123.02% | +129.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 670K 578K 544K 497K 928K 63.58M 934K 6.44M 32.43M 2.51M 2.46M 106M | - |
| Net income | -54.4M -14.58M -12.58M -11.84M -10.82M -20.2M -1.38B -20.32M -140M -706M -54.7M -53.53M -2.32B | 400M 107M 92.58M 87.2M 79.64M 149M 10.19B 150M 1.03B 5.2B 403M 394M 17.06B |
| Net Debt | -97.1M -26.02M -22.45M -21.14M -19.31M -36.06M -2.47B -36.27M -250M -1.26B -97.64M -95.54M -4.14B | -494M -132M -114M -108M -98.27M -184M -12.57B -185M -1.27B -6.41B -497M -486M -21.05B |
Employees
-
Calendar
Sep. 29
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | PLN 130.00 | -1.07% | 3,441 |
| 26-09-01 | PLN 131.40 | -1.94% | 622 |
| 26-08-31 | PLN 134.00 | -2.05% | 1,427 |
| 26-08-28 | PLN 136.80 | -0.44% | 1,408 |
| 26-08-27 | PLN 137.40 | -2.00% | 1,100 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
130.00PLN
Average target price
223.90PLN
Spread / Average Target
+72.23%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCP Stock
Select your edition
All financial news and data tailored to specific country editions
